Felodipine nanosuspension: A faster in vitro dissolution rate and higher oral absorption efficiency

Journal of Drug Delivery Science and Technology

Volumn 24, Issue 2, 2014, Pages 173-177

  Luo, Cong ^a   Li, Yan ^a   Sun, Jin ^a,b   Zhang, Yan ^c   Chen, Qin ^a   Liu, Xiaohong ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

^c Northeast Pharmaceutical Group Co Ltd   (China)

Author keywords

Characterization; Dissolution rate; Felodipine; Nanocrystals; Oral bioavailability

Indexed keywords

FELODIPINE; NANOCRYSTAL;

ANALYTIC METHOD; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BEAGLE; COLLOID; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGY; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; SINGLE DRUG DOSE; SUSPENSION; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84899497996     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(14)50028-7     Document Type: Article

References (25)

1. Wu C.Y., Benet L.Z. - Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. - Pharm. Res., 22, 11-23, 2005.
2. Kesisoglou F., Mitra A. - Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds. - The AAPS J., 14, 677-687, 2012.
3. Kesisoglou F., Panmai S., Wu Y. - Nanosizing - oral formulation development and biopharmaceutical evaluation. - Adv. Drug Deliv. Rev., 59, 631-644, 2007. (Pubitemid 47285408)
4. Kawabata Y., Wada K., Nakatani M., Yamada S., Onoue S. -Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. - Int. J. Pharm., 420, 1-10, 2011.
5. Fu Q., Sun J., Ai X., Zhang P., Li M., Wang Y., Liu X., Sun Y., Sui X., Sun L., Han X., Zhu M., Zhang Y., Wang S., He Z. -Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. - Int. J. Pharm., 448, 290-297, 2013.
6. Moribe K., Ueda K., Limwikrant W., Higashi K., Yamamoto K. - Nano-sized crystalline drug production by milling technology. - Curr Pharm Des., 2013.
7. Pathak P., Meziani M.J., Desai T., Sun Y. P. - Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing. - J. Supercrit. Fluids., 37, 279-286, 2006.
8. Yao L., Zhao X., Li Q., Zu Y., Fu Y., Zu B., Meng X., Liu C. - In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity. - Int. J. Pharm., 423, 586-588, 2012.
9. Venkataraman M., Nagarsenker M. - Silver sulfadiazine nanosystems for bum therapy. - AAPS PharmSciTech., 14, 254-264, 2013.
10. Lindfors L., Forssen S., Westergren J., Olsson U. - Nucleation and crystal growth in supersaturated solutions of a model drug. - J. Colloid Interface Sci., 325, 404-413, 2008.
11. Douroumis D., Fahr A. - Stable carbamazepine colloidal systems using the cosolvent technique. - Eur. J. Pharm. Sci., 30, 367-374, 2007. (Pubitemid 46436452)
12. Barbosa M.C., Messmer N.R., Brazil T.R., Marciano F.R., Lobo A.O. - The effect of ultrasonic irradiation on the crystallinity of nano-hydroxyapatite produced via the wet chemical method. -Mater. Sci. Eng. C Mater. Biol. Appl., 33, 2620-2625, 2013.
13. Luque de Castro M.D., Priego-Capote F. - Ultrasound-assisted crystallization (sonocrystallization). - Ultrason. Sonochem., 14, 717-724, 2007.
14. Xia D.N., Quan P., Piao H.Z., Piao H.Y., Sun S.P., Yin Y.M., Cui F.D.-Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. - Eur. J. Pharm. Sci., 40, 325-334, 2010.
15. Yedinak K.C., Lopez L.M. - Felodipine: a new dihydropyridine calcium-channel antagonist. - Ann. Pharmacother., 25, 1193-1206, 1991.
16. Edgar B., Collste P., Haglund K., Regardh C.G. - Pharmacokinetics and haemodynamics of felodipine as monotherapy in hypertensive patients. - Drugs, 34, 28-29, 1987.
17. Sahu B.P., Das M.K. - Nanosuspension for enhancement of oral bioavailability of felodipine. - Appl Nanosci., 2013.
18. Chen C., Xie X., Li Y., Zhou C., Song Y., Yan Z., Yang X. - Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions. - Drug Dev. Ind. Pharm., 2013.
19. Zimmermann A., Millqvist-Fureby A., Elema M.R., Hansen T., Mullertz A., Hovgaard L. - Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. - Eur. J. Pharm. Biopharm., 71, 109-116, 2009.
20. Raghavan S.L., Trividic A., Davis A.F., Hadgraft J. - Crystallization of hydrocortisone acetate: influence of polymers. - Int. J. Pharm., 212, 213-221, 2001. (Pubitemid 32119447)
21. Guo Z., Zhang M., Li H., Wang J., Kougoulos E. - Effect of ultrasound on antisolvent crystallization process. - J. Cryst. Growth., 273, 555-563, 2005.
22. Santander-Ortega M.J., Jodar-Reyes A.B., Csaba N., Bastos-Gonzalez D., Ortega-Vinuesa J.L. - Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. - J Colloid Interface Sci., 302, 522-529, 2006.
23. Hintz R.J., Johnson K.C. - The effect of particle size distribution on dissolution rate and oral absorption. - Int. J. Pharm., 51, 9-17, 1989.
24. Jia L., Wong H., Cerna C., Weitman S.D. - Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. - Pharm. Res., 19, 1091-1096, 2002. (Pubitemid 34984991)
25. Sahay G., Alakhova D.Y., Kabanov A. V. - Endocytosis of nanomedicines. - J. Control. Release, 145, 182-195, 2010.